We are live on ! Find out more
PCA

Personal Capital Advisors Portfolio holdings

AUM $20.6B
1-Year Est. Return 13.65%
This Fund
S&P 500
This Quarter Est. Return
+13.38%
1 Year Est. Return
-13.65%
3 Year Est. Return
+17.55%
5 Year Est. Return
+33.04%
10 Year Est. Return
–
AUM
$15.7B
AUM Growth
+$2.38B
Cap. Flow
+$739M
Cap. Flow %
4.72%
Top 10 Hldgs %
43.44%
Holding
475
New
57
Increased
296
Reduced
86
Closed
18

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$63M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$39.8M
3
MNST icon
Monster Beverage
MNST
+$38.6M
4
APD icon
Air Products & Chemicals
APD
+$37.8M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$37.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$19.4M
2
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$17.2M
3
ADM icon
Archer Daniels Midland
ADM
+$15.9M
4
CMCSA icon
Comcast
CMCSA
+$15M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$15M

Sector Composition

Rank Sector Weight
1 Technology 6.21%
2 Materials 4.41%
3 Consumer Discretionary 4.27%
4 Communication Services 4.05%
5 Consumer Staples 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRKR icon
451
Marker Therapeutics
MRKR
$18.8M
$37K ﹤0.01%
2,571
– –
GNCA
452
DELISTED
Genocea Biosciences, Inc.
GNCA
$36K ﹤0.01%
+15,000
New +$34.2K
ATHX
453
DELISTED
Athersys, Inc. Common Stock
ATHX
$35K ﹤0.01%
800
– –
MNKD icon
454
MannKind Corp
MNKD
$1.21B
$33K ﹤0.01%
10,530
– –
TRVN
455
DELISTED
Trevena, Inc.
TRVN
$25K ﹤0.01%
+18
New +$28.6K
LYG icon
456
Lloyds Banking Group
LYG
$89.5B
$24K ﹤0.01%
12,067
+1
+0% +$2
TXMD icon
457
TherapeuticsMD
TXMD
$23.5M
$16K ﹤0.01%
260
– –
AVUS icon
458
Avantis US Equity ETF
AVUS
$14.2B
– –
-4,059
Closed -$220K
BIIB icon
459
Biogen
BIIB
$30B
– –
-830
Closed -$235K
CRVO icon
460
CervoMed
CRVO
$23.9M
– –
-133
Closed -$8K
DSI icon
461
iShares MSCI KLD 400 Social ETF
DSI
$5.43B
– –
-3,692
Closed -$236K
EPD icon
462
Enterprise Products Partners
EPD
$82.3B
– –
-10,894
Closed -$172K
F icon
463
Ford
F
$58.5B
– –
-16,379
Closed -$109K
FATE icon
464
Fate Therapeutics
FATE
$286M
– –
-6,011
Closed -$240K
MDY icon
465
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
– –
-3,356
Closed -$1.14M
NVAX icon
466
Novavax
NVAX
$1.2B
– –
-3,349
Closed -$363K
NWSA icon
467
News Corp Class A
NWSA
$14.9B
– –
-91,065
Closed -$1.28M
SUSA icon
468
iShares ESG Optimized MSCI USA ETF
SUSA
$4.08B
– –
-3,516
Closed -$259K
UAMY icon
469
United States Antimony
UAMY
$751M
– –
-15,000
Closed -$4K
VGSH icon
470
Vanguard Short-Term Treasury ETF
VGSH
$29.2B
– –
-3,555
Closed -$221K
XLB icon
471
State Street Materials Select Sector SPDR ETF
XLB
$8.36B
– –
-123,580
Closed -$3.93M
XLC icon
472
State Street Communication Services Select Sector SPDR ETF
XLC
$22.4B
– –
-53,114
Closed -$3.15M
SILK
473
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-3,129
Closed -$210K
POLY
474
DELISTED
Plantronics, Inc.
POLY
– –
-43,837
Closed -$519K
UN
475
DELISTED
Unilever NV New York Registry Shares
UN
– –
-3,615
Closed -$218K
15 16 17 18
19

Similar funds

PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AIM
Allstate Investment Management Chicago, Illinois $3.29B AUM
AAM
Abeille Asset Management France $2.82B AUM 15.24% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
GJIC
Gamble Jones Investment Counsel Pasadena, California $1.33B AUM 11.55% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Personal Capital Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Personal Capital Advisors held 475 positions worth $15.7B, up 18% from $13.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Personal Capital Advisors deployed $739M of net new capital in Q4 2020, opening 57 new positions and adding to 296 existing holdings. Its largest new stake was Monster Beverage: 918,940 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Materials and Consumer Discretionary.

On the sell side, the largest reduction was ExxonMobil, an estimated $19.4M trimmed.

  • Personal Capital Advisors's largest Q4 2020 buy was Monster Beverage: 918,940 shares worth $42.5M.
  • Personal Capital Advisors added most to Vanguard Short-Term Bond ETF in Q4 2020, an estimated $63M increase.
  • Personal Capital Advisors's biggest Q4 2020 reduction was ExxonMobil, cutting an estimated $19.4M.
  • Personal Capital Advisors fully exited State Street Materials Select Sector SPDR ETF in Q4 2020, selling an estimated $3.93M.
  • Personal Capital Advisors's ten largest holdings make up 43% of its $15.7B portfolio in Q4 2020.
  • Personal Capital Advisors opened 57 new positions and closed 18 in Q4 2020.
  • Personal Capital Advisors's portfolio value rose 18% quarter-over-quarter to $15.7B.

Based on Personal Capital Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.